Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,305 papers from all fields of science
Search
Sign In
Create Free Account
Stage III Nasopharyngeal Carcinoma
Known as:
stage III nasopharynx cancer
, Stage III Nasopharyngeal Carcinoma AJCC v7
, Nasopharyngeal Cancer, Stage III AJCC v6
Expand
Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Chromosome 13q deletion
Epithelial Cells
Epithelium
HLA-A gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
RESPONSE OUTCOMES OF CONCURRENT CHEMORADIOTHERAPY (CCRT) FOR STAGE III NASOPHARYNGEAL CARCINOMA
Feri Danil
2020
Corpus ID: 216195189
Introduction: Nasopharyngeal carcinoma (NPC) is a rare malignancy with an incidence of 0.5-2 per 100,000 in Europe and the…
Expand
2018
2018
EP-1135: Effects of different treatment and EBV viral load in stage III nasopharyngeal carcinoma patients
J. Lin
,
W. Wen-yi
,
L. Yi-chun
2018
Corpus ID: 80736242
2012
2012
Efficacy of clinical stage III nasopharyngeal carcinoma treated by intensity-modulated radiation therapy combined with chemotherapy
Lin Jin
2012
Corpus ID: 76633573
Background and purpose:Intensity-modulated radiation therapy(IMRT) enables the delivery of higher radiation dose to the primary…
Expand
2011
2011
Effect of concomitant chemotherapy on prognosis of patients with stage III nasopharyngeal carcinoma after radiotherapy:A retrospective analysis
Zheng Ming-zhang
2011
Corpus ID: 76646544
OBJECTIVE:To evaluate the impacts of chemotherapy combined with radiotherapy on the survival of patients suffered from stage…
Expand
2008
2008
Relationship between the expression of protein p53 or LMP-1 and the prognosis of patients with stage III nasopharyngeal carcinoma
Zhang Wei-yuan
2008
Corpus ID: 75484684
Objective To investigate p53 protein and LMP-1 protein expression in stage Ⅲ nasopharyngeal differentiated non-keratinizing…
Expand
2008
2008
Expressions and significance of hMLH1 and p53 protein with clinical pathological features at stage III nasopharyngeal carcinoma
X. Shu
2008
Corpus ID: 87377077
Objective To investigate the expression of hMLH1 and p53 protein at stageⅢnasopharyngeal poorly dif- ferentiated squamous cell…
Expand
2007
2007
Nursing intervention in patients with stage III nasopharyngeal carcinoma treated by combined radiotherapy and chemotherapy.
Deng Jin-ron
2007
Corpus ID: 76120996
Objective To explore the effect of nursing intervention in patients with advanced nasopharyngeal carcinoma treated with combined…
Expand
2005
2005
Concurrent chemoradiotherapy using biweekly cisplatin/tegafur plus uracil/leucovorin in stage III nasopharyngeal carcinoma
Hung-Ming Wang
,
P.-T. Chen
,
+4 authors
I-Hsuan Chen
2005
Corpus ID: 74453447
5510 Background: Concomitant chemoradiotherapy (CCRT) is considered to be the most effective way to improve overall survival in…
Expand
2001
2001
[Study on the correlation between the expression of protein p53 at stage III nasopharyngeal carcinoma and its biological behavior, prognosis, p53 gene mutation and the expression of LMP-1].
S. Xu
,
W. Zhang
Zhonghua bing li xue za zhi = Chinese journal of…
2001
Corpus ID: 31259430
OBJECTIVE To investigate p53 protein expression at stage III nasopharyngeal differentiated non-keratinizing squamous carcinoma…
Expand
1999
1999
[Immunocyte reaction in stage III nasopharyngeal carcinoma in relation to biological findings and prognosis].
C. He
,
H. Zhuang
,
W. Zhang
Zhonghua bing li xue za zhi = Chinese journal of…
1999
Corpus ID: 45460625
OBJECTIVE To study the relationship between macrophages (MP), Langerhans cells (LC), T and B lymphocytes, biological behavior and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE